Nyxoah SA (NYXH) vs QTREX Quantum (QTEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
QTREX Quantum (QTEX) has outperformed Nyxoah SA (NYXH) over the past year, gaining 53.3% versus a loss of 78.7%. Over five years, QTEX leads with a -22.7% price change compared with -94.7% for NYXH. Nyxoah SA is the larger company by market cap ($138.5 million vs $125.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NYXH | QTEX |
|---|---|---|
| Share price | $1.36 | $1.87 |
| Market cap | $138.50M | $125.43M |
| 1-day change | +0.74% | +10.65% |
| YTD return | -70.43% | +107.78% |
| 1-year return | -78.72% | +53.28% |
| 5-year return | -94.67% | -22.73% |
| EPS (TTM) | $-2.56 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.60 | $3.85 |
| 52-week low | $1.26 | $0.283 |
| Distance from 52-week high | -79.39% | -51.43% |
| Analyst consensus | none | none |
| Avg. price target upside | +208.82% | +167.38% |
| Average volume | 272.93K | 8.44M |
| Shares outstanding | 101.84M | 67.08M |
| Employees | 153 | 34 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QTEX has outperformed NYXH by 132.0 percentage points over the past year.
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
About QTREX Quantum
QTEX stock →QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
Health Care · Medical/Dental Instruments · 34 employees
NYXH vs QTEX FAQ
Which is bigger, Nyxoah SA or QTREX Quantum?
Nyxoah SA (NYXH) is larger, with a market capitalization of $138.50M compared with $125.43M for QTREX Quantum (QTEX).
Which stock has performed better over the past year, NYXH or QTEX?
QTEX returned +53.28% over the past 12 months, compared with -78.72% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Nyxoah SA and QTREX Quantum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.